CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination. (2022)

First Author: Sharpe HR
Attributed to:  The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.154187

PubMed Identifier: 35192547

Publication URI: http://europepmc.org/abstract/MED/35192547

Type: Journal Article/Review

Volume: 7

Parent Publication: JCI insight

Issue: 6

ISSN: 2379-3708